Clene Inc.
General ticker "CLNN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $41.5M (TTM average)
Clene Inc. follows the US Stock Market performance with the rate: 40.7%.
Estimated limits based on current volatility of 3.4%: low 6.37$, high 6.82$
Factors to consider:
- Total employees count: 85 (-1.2%) as of 2023
- Top business risk factors: Economic downturns and volatility, Product commercialization failure, Labor/talent shortage/retention, Manufacturing disruptions, Inflation impact
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.29$, 13.98$]
- 2026-12-31 to 2027-12-31 estimated range: [2.82$, 9.70$]
Financial Metrics affecting the CLNN estimates:
- Positive: with PPE of -2.1 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -30.21 <= 0.07
- Positive: Investing cash flow per share per price, % of -0.06 > -0.65
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Shareholder equity ratio, % of -97.03 <= 19.49
Short-term CLNN quotes
Long-term CLNN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.65MM | $0.34MM | $0.20MM |
| Operating Expenses | $41.19MM | $33.44MM | $23.28MM |
| Operating Income | $-40.54MM | $-33.09MM | $-23.08MM |
| Non-Operating Income | $-8.96MM | $-6.31MM | $-3.09MM |
| Interest Expense | $4.56MM | $4.06MM | $2.68MM |
| R&D Expense | $26.66MM | $20.06MM | $14.01MM |
| Income(Loss) | $-49.50MM | $-39.40MM | $-26.17MM |
| Profit(Loss)* | $-49.50MM | $-39.40MM | $-26.17MM |
| Stockholders Equity | $13.39MM | $-8.86MM | $-17.59MM |
| Inventory | $0.04MM | $0.07MM | $0.04MM |
| Assets | $52.34MM | $27.34MM | $18.13MM |
| Operating Cash Flow | $-30.17MM | $-21.33MM | $-18.55MM |
| Capital expenditure | $0.33MM | $0.01MM | $0.04MM |
| Investing Cash Flow | $-1.50MM | $6.32MM | $-0.04MM |
| Financing Cash Flow | $42.16MM | $-1.53MM | $11.52MM |
| Earnings Per Share** | $-9.43 | $-5.67 | $-2.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.